Yervoy (ipilimumab) 50 mg/10 mL, 1 vial, Bristol Myers Squibb, original Yervoy (ipilimumab) is used for approved oncology indications including melanoma and renal cell carcinoma. Order at +380996042415 via Viber or WhatsApp.
Delivery methods
- Delivery of non-temperature-controlled medicines to Chisinau - $25.
Delivery of temperature-controlled medicines to Chisinau - $50.
Up to 5 packages can be sent per shipment. The price applies to one shipment. - Pickup from Odesafree
- Shipping within Ukraine by Nova Poshta at the carrier's rates.
Payment in UAH upon receipt of the order.
Delivery time
- Originator medicines: 5-7 days
- Generic medicines: 3-4 days
Payment methods
- Bank transfer to the settlement account after receiving the order
- Payment upon pickup in Odesa
Indications: Yervoy (ipilimumab) is a CTLA-4-blocking antibody used alone or in combination with nivolumab for approved oncology indications, including melanoma and selected other cancers.
Yervoy is administered by intravenous infusion. The dose, interval and duration depend on the cancer type and treatment combination. It must be prescribed and supervised by an oncology specialist because severe and potentially fatal immune-mediated adverse reactions can occur.
- Trade name:Yervoy
- Chemical name:Ipilimumab
- Dosage:50
- Quantity:1
- Dosage form:Vial
- Manufacturer:Bristol Myers Squibb
No reviews yet